|  
Home
Provigil Information
A Solution for Sleepiness
Taking Provigil
Off-Label Provigil
Use
Journal Articles
Related Resources
Provigil in the News
About Provigil Web
|
 |
 |
 |

Journal of Affective Disorders
Volume 81, Issue 2 , August 2004, Pages 173-178
Modafinil treatment in patients with seasonal affective disorder/winter
depression: an open-label pilot study
Leslie Lundt
Background: Hypersomnia is a cardinal symptom of seasonal
affective disorder/winter depression. This open-label pilot study assessed
modafinil, a novel wake-promoting agent, as treatment for seasonal affective
disorder/winter depression. Methods: Total daily modafinil dose was 100
mg (all patients week 1), and 100 mg or 200 mg split dose (weeks 2–8).
Efficacy assessments (weeks 1, 2, 5, and 8) included the Structured Interview
Guide for the Hamilton Depression (HAM-D) Rating Scale, Seasonal Affective
Disorder Version (SIGH-SAD), Montgomery–Asberg Depression Rating
Scale (MADRS), Clinical Global Impression of Change (CGI-C), Fatigue Severity
Scale (FSS), and Epworth Sleepiness Scale (ESS).
Results: Thirteen patients (11 women; mean age, 41 years)
were enrolled, 12 were evaluable for efficacy (100 mg dose, five patients;
200 mg dose, seven patients), and nine completed treatment. Modafinil
significantly improved winter depression as shown by reductions from baseline
in mean SIGH-SAD at week 1 (P<0.01) through week 8 (P<0.001 weeks
2–8) and MADRS total scores from week 2 through week 8 (P<0.01
for all). At week 8, mean SIGH-SAD total score was 17.1 (versus 37.2 at
baseline, P<0.001), and mean MADRS total score was 13.3 (versus 26.9
at baseline, P<0.01). Modafinil significantly improved overall clinical
condition at all time points (P<0.001). The response rate was 67% on
the SIGH-SAD (29 item), HAM-D (21 item), and MADRS, and 100% on eight
atypical SIGH-SAD items. Modafinil significantly reduced fatigue (FSS)
and improved wakefulness (ESS) from weeks 2 through 8 (P<0.01). Modafinil
was well tolerated.
Limitations: This was an open-label, single site study.
Conclusions: Modafinil may be an effective and well-tolerated
treatment in patients with seasonal affective disorder/winter depression.
|
|